Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

62.95
+0.76001.22%
Post-market: 62.85-0.0969-0.15%18:46 EDT
Volume:1.85M
Turnover:115.64M
Market Cap:7.75B
PE:-9.63
High:63.80
Open:62.00
Low:61.53
Close:62.19
52wk High:70.98
52wk Low:29.31
Shares:123.16M
Float Shares:119.09M
Volume Ratio:0.80
T/O Rate:1.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.5400
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-27.08%
PB:-11.75
PE(LYR):-9.63

Loading ...

U.S. RESEARCH ROUNDUP-Carnival, Five Below, McKesson

Reuters
·
Yesterday

Cytokinetics Insiders Make Bold Moves With Fresh Wave of Stock Sales

TIPRANKS
·
Yesterday

Cytokinetics EVP and Chief Commercial Officer Andrew Callos disposes of USD 119,805 in common shares

Reuters
·
Yesterday

Cytokinetics Grants 8,628 Stock Options at USD 60.06 Under Nasdaq Inducement Rule

Reuters
·
Yesterday

Cytokinetics price target raised to $100 from $84 at Mizuho

TIPRANKS
·
Yesterday

Cytokinetics Is Maintained at Overweight by JP Morgan

Dow Jones
·
Mar 17

U.S. RESEARCH ROUNDUP- Biogen, Eli Lilly, Johnson & Johnson

Reuters
·
Mar 17

Cytokinetics Inc : JP Morgan Adds Stock to Its US Analyst Focus List

THOMSON REUTERS
·
Mar 17

Cytokinetics EVP and Chief Commercial Officer Andrew Callos disposes of USD 104,319 in common shares

Reuters
·
Mar 17

Cytokinetics Announces Four Presentations at the American College of Cardiology Annual Scientific Session & Expo

GlobeNewswire
·
Mar 16

Top Cytokinetics Executives Quietly Cash In on Major Stock Sales

TIPRANKS
·
Mar 11

A Look At Cytokinetics (CYTK) Valuation After Analyst Updates And Myqorzo Launch

Simply Wall St.
·
Mar 10

Cytokinetics Is Maintained at Neutral by UBS

Dow Jones
·
Mar 07

Top Cytokinetics Executive Makes Eye-Catching Move With Major Stock Sale

TIPRANKS
·
Mar 06

Cytokinetics Earnings Call Marks High-Stakes Launch Phase

TIPRANKS
·
Mar 06

Top Cytokinetics Insiders Quietly Cash Out in Notable Stock Moves

TIPRANKS
·
Mar 03

Cytokinetics EVP and Chief Commercial Officer Andrew Callos Disposes of Common Shares

Reuters
·
Mar 03

Cytokinetics Management Team to Participate in March Investor Conferences

Reuters
·
Mar 03

FDA Disruptions and Budget Cuts Pose Rising Regulatory Risk to Cytokinetics’ Drug Pipeline

TIPRANKS
·
Feb 28

Cytokinetics management to meet with B. Riley

TIPRANKS
·
Feb 28